1. What is LUMIGAN®?
LUMIGAN® ophthalmic solution is a medicated eyedrop that's proven
to lower elevated IOP. The only treatable risk factor for glaucoma is elevated IOP.
The best way to manage glaucoma is to lower your IOP and follow your eye doctor's
instructions.
2. Will LUMIGAN® cure my glaucoma?
Though there is no cure for glaucoma, reducing IOP is the best way to manage glaucoma
and prevent vision loss. It is important to lower your IOP because up to 40% of
your optic nerve may be damaged before you notice any difference in your vision.
That's why early detection and ongoing treatment are so vital.
3. Why did my doctor choose LUMIGAN® therapy?
The most common treatment to reduce elevated IOP is medicated eyedrops. Your doctor
prescribed once-daily LUMIGAN® ophthalmic solution, an FDA-approved
medication proven to lower IOP in newly diagnosed or already-treated patients with
open-angle glaucoma or ocular hypertension.
4. How do I use LUMIGAN®?
LUMIGAN® eyedrops are used once a day. Visit How to Use LUMIGAN® Drops
for instructions on how to put LUMIGAN® ophthalmic solution in your
eyes.
5. What are the most common side effects of LUMIGAN®?
With LUMIGAN® ophthalmic solution, side effects are usually tolerable.
You may experience increased eyelash growth, itchy eyes, or temporary eye redness
(hyperemia). Eye redness can occur immediately after use but usually lasts only
a few weeks. Your eyes may get red but typically won't hurt or itch. (Call your
doctor if they do.) In clinical studies, approximately 3% of patients taking LUMIGAN®
stopped taking LUMIGAN® due to eye redness.
6. What can I do to manage my glaucoma?
The best way to manage your glaucoma is to lower your eye pressure by taking your
LUMIGAN® once daily as prescribed by your doctor. Do not stop taking
LUMIGAN® eyedrops without talking to your eye doctor first.
LUMIGAN® 0.01% and 0.03% (bimatoprost ophthalmic solution) is used
for the treatment of high eye pressure, also called intraocular pressure (IOP),
in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
LUMIGAN® 0.01% and 0.03% (bimatoprost ophthalmic solution) has been
reported to cause darkening (pigmentation) of eye color, eyelid skin, and eyelashes
as well as increased growth of eyelashes. Pigmentation changes can increase as long
as LUMIGAN® 0.01% and 0.03% is used. After stopping LUMIGAN®
0.01% and 0.03%, darkening of eye color is likely to be permanent, while darkening
of the eyelid skin and eyelash changes may be reversible. The effects of increased
darkening beyond 5 years are not known.
When only one eye is treated, there is a possibility of eyelash changes in the eye
treated with LUMIGAN® 0.01% and 0.03%. These changes may result in
differences between the eyes in eyelash length, thickness, darkness, number of eyelashes,
and/or direction of eyelash growth. These changes are usually reversible upon stopping
LUMIGAN® 0.01% and 0.03% therapy.
Avoid allowing the tip of the dispensing bottle to touch the eye, anything around
the eye, fingers, or any other surface in order to avoid contamination by common
bacteria known to cause eye infections. Serious damage to the eye and loss of vision
may result from using contaminated solutions.
If you have eye surgery or develop any eye reactions (such as trauma or infection),
immediately consult with your physician about continuing the use of LUMIGAN®
0.01% and 0.03%.
If you wear contact lenses, remove them before using LUMIGAN® 0.01%
and 0.03%. Then wait 15 minutes after using LUMIGAN® 0.01% and 0.03%
before you put your contacts back into your eyes.
The most common side effects are eye redness, growth of eyelashes, and itchy eyes.
Click here
for full prescribing information.